首页> 外国专利> PROGNOSTIC MARKERS IN LUNG CANCER, PROGNOSTIC TYPING MODEL OF LUNG CANCER, AND APPLICATION THEREOF

PROGNOSTIC MARKERS IN LUNG CANCER, PROGNOSTIC TYPING MODEL OF LUNG CANCER, AND APPLICATION THEREOF

机译:肺癌的预后标志物,肺癌的预后分型模型及其应用

摘要

Provided in the present application are prognostic markers in lung cancer, a prognostic typing model of lung cancer, and application thereof. The markers include imprinted genes Dcn, Peg10, Snrpn/Snurf and Trappc9. The four imprinted genes Dcn, Peg10, Snrpn/Snurf and Trappc9 of the present application have a significant correlation with prognosis of lung cancer. The imprinted gene Dcn is the most sensitive and specific marker of prognosis of lung cancer, which precedes clinicopathological features. A prognostic typing model of lung cancer can be constructed using the product of a total expression amount and a copy number variation expression amount of the four imprinted genes. The prognostic typing model of lung cancer can be used for personalized prediction of five-year survival time of lung cancer patients to provide accurate and useful prognostic information for the lung cancer patients.
机译:本申请中提供了肺癌的预后标志物,肺癌的预后分型模型及其应用。标记包括印迹基因Dcn,Peg10,Snrpn / Snurf和Trappc9。本申请的四个印迹基因Dcn,Peg10,Snrpn / Snurf和Trappc9与肺癌的预后具有显着相关性。印记的基因Dcn是肺癌预后中最敏感,最特异的标志物,在临床病理特征之前。可以使用四个印迹基因的总表达量和拷贝数变异表达量的乘积来构建肺癌的预后分型模型。肺癌的预后分型模型可用于个性化预测肺癌患者的五年生存时间,从而为肺癌患者提供准确而有用的预后信息。

著录项

  • 公开/公告号WO2020103905A1

    专利类型

  • 公开/公告日2020-05-28

    原文格式PDF

  • 申请/专利权人 LISEN IMPRINTING DIAGNOSTICS INC.;LI XING;

    申请/专利号WO2019CN119966

  • 发明设计人 CHENG TONG;ZHOU NING;

    申请日2019-11-21

  • 分类号C12Q1/6886;A61K48;A61P35;C12N15/11;

  • 国家 WO

  • 入库时间 2022-08-21 11:11:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号